These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

328 related items for PubMed ID: 7889311

  • 1. Two populations of muscarinic binding sites in the chick heart distinguished by affinities for ligands and selective inactivation.
    Jakubík J, Tucek S.
    Br J Pharmacol; 1994 Dec; 113(4):1529-37. PubMed ID: 7889311
    [Abstract] [Full Text] [Related]

  • 2. Radioligand binding characteristics of the chicken cardiac muscarinic receptor.
    Michel AD, Whiting RL.
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Sep; 340(3):279-84. PubMed ID: 2812039
    [Abstract] [Full Text] [Related]

  • 3. Affinities of muscarinic drugs for [3H]N-methylscopolamine (NMS) and [3H]oxotremorine (OXO) binding to a mixture of M1-M4 muscarinic receptors: use of NMS/OXO-M ratios to group compounds into potential agonist, partial agonist, and antagonist classes.
    Sharif NA, Williams GW, DeSantis LM.
    Neurochem Res; 1995 Jun; 20(6):669-74. PubMed ID: 7566362
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Distinct kinetic binding properties of N-[3H]-methylscopolamine afford differential labeling and localization of M1, M2, and M3 muscarinic receptor subtypes in primate brain.
    Flynn DD, Mash DC.
    Synapse; 1993 Aug; 14(4):283-96. PubMed ID: 8248852
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Irreversible and quaternary muscarinic antagonists discriminate multiple muscarinic receptor binding sites in rat brain.
    Norman AB, Eubanks JH, Creese I.
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1116-22. PubMed ID: 2703964
    [Abstract] [Full Text] [Related]

  • 12. N-[3H]methylscopolamine labeling of non-M1, non-M2 muscarinic receptor binding sites in rat brain.
    Smith TD, Annis SJ, Ehlert FJ, Leslie FM.
    J Pharmacol Exp Ther; 1991 Mar; 256(3):1173-81. PubMed ID: 2005579
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pharmacological characterization of muscarinic receptors in neonatal rat cardiomyocytes.
    Yang CM, Chen FF, Sung TC, Hsu HF, Wu D.
    Am J Physiol; 1993 Sep; 265(3 Pt 1):C666-73. PubMed ID: 8214023
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The binding of [3H]4-diphenylacetoxy-N-methylpiperidine methiodide to longitudinal ileal smooth muscle muscarinic receptors.
    Michel AD, Whiting RL.
    Eur J Pharmacol; 1990 Feb 06; 176(2):197-205. PubMed ID: 2311667
    [Abstract] [Full Text] [Related]

  • 20. Modes of allosteric interactions with free and [3H]N-methylscopolamine-occupied muscarinic M2 receptors as deduced from buffer-dependent potency shifts.
    Schröter A, Tränkle C, Mohr K.
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Dec 06; 362(6):512-9. PubMed ID: 11138843
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.